In silico and in vivo studies of Astragalus glycyphylloides saponin(s) with relevance to metabolic syndrome modulation
- 1 August 2019
- journal article
- conference paper
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 130, 317-325
Abstract
No abstract availableKeywords
Funding Information
- Bulgarian National Science Fund (DM 01/1/2016)
- Ministry of Education and Science (577/17.08.2018)
This publication has 36 references indexed in Scilit:
- Identification and Characterization of Reactive Metabolites in Natural Products-Driven Drug DiscoveryJournal of Natural Products, 2012
- Diabetes and Hypertension: Is There a Common Metabolic Pathway?Current Atherosclerosis Reports, 2012
- Effect of triterpenes and triterpene saponins from the stem bark of Kalopanax pictus on the transactivational activities of three PPAR subtypesCarbohydrate Research, 2011
- Differential Responses to Blood Pressure and Oxidative Stress in Streptozotocin-Induced Diabetic Wistar-Kyoto Rats and Spontaneously Hypertensive Rats: Effects of Antioxidant (Honey) TreatmentInternational Journal of Molecular Sciences, 2011
- Pioglitazone abrogates cyclosporine-evoked hypertension via rectifying abnormalities in vascular endothelial functionBiochemical Pharmacology, 2011
- Lipid abnormalities in streptozotocin-diabetes: Amelioration by Morus indica L. cv Suguna leavesInternational Journal of Diabetes in Developing Countries, 2009
- In Silico Tools for Sharing Data and Knowledge on Toxicity and Metabolism: Derek for Windows, Meteor, and ViticToxicology Mechanisms and Methods, 2008
- Pioglitazone, a PPAR? agonist, restores endothelial function in aorta of streptozotocin-induced diabetic ratsCardiovascular Research, 2005
- Hypoglycemic and hypolipidemic effects of tectorigenin and kaikasaponin III in the streptozotocin-induced diabetic rat and their antioxidant activityin vitroArchives of Pharmacal Research, 2000
- Pharmacology of oleanolic acid and ursolic acidJournal of Ethnopharmacology, 1995